Cellect Biotechnology Ltd. (Nasdaq: APOP) received a notice of allowance from the U.S. Patent & Trademark Office for a patent to protect the company's technology to treat multiple medical conditions. The stock price surged $2.79 to close at $6.11.
Collect Biotechnology receives notice of allowance
January 12, 2017 at 16:36 PM EST
